Blb&B Advisors, LLC Ionis Pharmaceuticals Inc Transaction History

Blb&B Advisors, LLC

$1.76 Billion
Q1 2024

A detailed history of Blb&B Advisors, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Blb&B Advisors, LLC holds 146,100 shares of IONS stock, worth $6.59 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares

146,100

Previous 147,100 0.68%

Holding current value

$6.59 Million

Previous $7.44 Million 14.89%

% of portfolio

0.36%

Previous 0.47%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 26, 2024	SELL	$42.03 - $53.55 $42,030 - $53,550	-1,000 Reduced 0.68%	146,100 $6.33 Million
Q4 2023 Jan 19, 2024	SELL	$43.39 - $51.63 $23,864 - $28,396	-550 Reduced 0.37%	147,100 $7.44 Million
Q3 2023 Oct 24, 2023	SELL	$38.5 - $47.13 $102,025 - $124,894	-2,650 Reduced 1.76%	147,650 $6.7 Million
Q2 2023 Jul 20, 2023	BUY	$34.73 - $43.33 $46,538 - $58,062	1,340 Added 0.9%	150,300 $6.17 Million
Q4 2022 Jan 17, 2023	SELL	$37.12 - $46.52 $4,083 - $5,117	-110 Reduced 0.07%	148,960 $0

Q3 2022 Oct 14, 2022	SELL	$36.54 - $48.66 $6,577 - $8,758	-180 Reduced 0.12%	149,070 $6.59 Million
Q2 2022 Jul 18, 2022	SELL	$31.71 - $43.0 $15,696 - $21,285	-495 Reduced 0.33%	149,250 $5.53 Million
Q1 2022 Apr 20, 2022	SELL	$29.88 - $37.04 $35,557 - $44,077	-1,190 Reduced 0.79%	149,745 $5.55 Million
Q4 2021 Jan 21, 2022	SELL	$25.61 - $35.1 $134,836 - $184,801	-5,265 Reduced 3.37%	150,935 $4.59 Million
Q3 2021 Oct 19, 2021	SELL	$33.54 - $40.55 $43,266 - $52,309	-1,290 Reduced 0.82%	156,200 $5.24 Million
Q2 2021 Jul 20, 2021	BUY	$34.54 - $47.25 $30,049 - $41,107	870 Added 0.56%	157,490 $6.28 Million
Q1 2021 Apr 19, 2021	SELL	$42.51 - $63.78 $45,273 - $67,925	-1,065 Reduced 0.68%	156,620 $7.04 Million
Q4 2020 Jan 19, 2021	SELL	$45.3 - $60.27 $890,824 - $1.19 Million	-19,665 Reduced 11.09%	157,685 $8.92 Million
Q3 2020 Oct 20, 2020	SELL	$47.45 - $62.95 $27,758 - $36,825	-585 Reduced 0.33%	177,350 $8.42 Million
Q2 2020 Jul 16, 2020	SELL	$46.85 - $61.05 $108,223 - $141,025	-2,310 Reduced 1.28%	177,935 $10.5 Million
Q1 2020 Apr 21, 2020	SELL	$41.6 - $63.4 $99,174 - $151,145	-2,384 Reduced 1.31%	180,245 $8.52 Million
Q4 2019 Jan 21, 2020	BUY	$53.85 - $65.27 $2,907 - $3,524	54 Added 0.03%	182,629 $11 Million
Q3 2019 Oct 22, 2019	SELL	$59.06 - $72.15 $77,073 - $94,155	-1,305 Reduced 0.71%	182,575 $10.9 Million
Q2 2019 Jul 29, 2019	SELL	$62.09 - $86.14 $27,009 - $37,470	-435 Reduced 0.24%	183,880 $11.8 Million
Q1 2019 Apr 19, 2019	SELL	$52.92 - $81.17 $3.33 Million - $5.1 Million	-62,841 Reduced 25.43%	184,315 $15 Million
Q4 2018 Jan 17, 2019	SELL	$43.37 - $59.54 $103,654 - $142,300	-2,390 Reduced 0.96%	247,156 $13.4 Million
Q3 2018 Oct 12, 2018	SELL	$42.88 - $53.7 $81,900 - $102,567	-1,910 Reduced 0.76%	249,546 $12.9 Million
Q2 2018 Jul 11, 2018	SELL	$40.53 - $50.7 $50,662 - $63,375	-1,250 Reduced 0.49%	251,456 $10.5 Million
Q1 2018 Apr 09, 2018	BUY	$44.08 - $55.05 $8.62 Million - $10.8 Million	195,555 Added 342.17%	252,706 $11.1 Million
Q4 2017 Jan 16, 2018	SELL	$50.3 - $64.39 $221,118 - $283,058	-4,396 Reduced 7.14%	57,151 $2.88 Million
Q3 2017 Oct 16, 2017	BUY	$45.56 - $59.57 $2.8 Million - $3.67 Million	61,547	61,547 $3.12 Million

Others Institutions Holding IONS

# of Institutions

397

Shares Held

122M

Call Options Held

854K

Put Options Held

464K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $6.41B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blb&B Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blb&B Advisors, LLC with notifications on news.

Account

Blb&B Advisors, LLC Ionis Pharmaceuticals Inc Transaction History